Optimizing radiation treatment plans for lung cancer using lung perfusion information.

PURPOSE To study the impact of incorporation of lung perfusion information in the optimization of radical radiotherapy (RT) treatment plans for patients with medically inoperable non-small cell lung cancer (NSCLC). MATERIALS AND METHODS The treatment plans for a virtual phantom and for five NSCLC patients with typical defects of pre-RT lung perfusion were optimized to minimize geometrically determined parameters as the mean lung dose (MLD), the lung volume receiving more than 20 Gy (V20), and the functional equivalent of the MLD, using perfusion-weighted dose-volume histograms. For the patients the (perfusion-weighted) optimized plans were compared to the clinically applied treatment plans. RESULTS The feasibility of perfusion-weighted optimization was demonstrated in the phantom. Using perfusion information resulted in an increase of the weights of those beams that were directed through the hypo-perfused lung regions both for the phantom and for the studied patients. The automatically optimized dose distributions were improved with respect to lung toxicity compared with the clinical treatment plans. For patients with one hypo-perfused hemi-thorax, the estimated gain in post-RT lung perfusion was 6% of the prescribed dose compared to the geometrically optimized plan. For patients with smaller perfusion defects, perfusion-weighted optimization resulted in the same plan as the geometrically optimized plan. CONCLUSION Perfusion-weighted optimization resulted in clinically well applicable treatment plans, which cause less radiation damage to functioning lung for patients with large perfusion defects.

[1]  L. Boersma,et al.  Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer. , 2000, International journal of radiation oncology, biology, physics.

[2]  L. Boersma,et al.  Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  P. Rubin,et al.  Long‐term observations of the patterns of failure in patients with unresectable non‐oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group , 1987, Cancer.

[4]  M. I. Saunders,et al.  Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee. , 1996, British Journal of Cancer.

[5]  M T Munley,et al.  Physical and biological predictors of changes in whole-lung function following thoracic irradiation. , 1997, International journal of radiation oncology, biology, physics.

[6]  R. Arriagada,et al.  Current strategies for radiation therapy in non-small cell lung cancer. , 1997, Chest.

[7]  P. Blitzer,et al.  Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy. , 1996, Seminars in radiation oncology.

[8]  R K Ten Haken,et al.  Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Lebesque,et al.  Dose escalation in NSCLC using three dimensional conformal radiotherapy (3 DCRT) , 2000 .

[10]  T G Turkington,et al.  The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation. , 1993, International journal of radiation oncology, biology, physics.

[11]  P Baas,et al.  Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  R. Jaszczak,et al.  The effect of patient-specific factors on radiation-induced regional lung injury. , 1999, International journal of radiation oncology, biology, physics.

[13]  M Engelsman,et al.  Impact of simple tissue inhomogeneity correction algorithms on conformal radiotherapy of lung tumours. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  R K Ten Haken,et al.  Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. , 1998, International journal of radiation oncology, biology, physics.

[15]  M Oldham,et al.  The optimization and inherent limitations of 3D conformal radiotherapy treatment plans of the prostate. , 1995, The British journal of radiology.

[16]  L B Marks,et al.  The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose-volume histogram. , 1995, International journal of radiation oncology, biology, physics.

[17]  Y Seppenwoolde,et al.  Partial irradiation of the lung. , 2001, Seminars in radiation oncology.

[18]  Icru.  Prescribing, recording, and reporting photon beam therapy , 1993 .

[19]  R K Ten Haken,et al.  Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. , 1999, Lung cancer.

[20]  M. Martel,et al.  Dose escalation for non-small cell lung cancer using conformal radiation therapy. , 1997, International journal of radiation oncology, biology, physics.

[21]  R Mackie,et al.  A new approach to dose escalation in non-small-cell lung cancer. , 2001, International journal of radiation oncology, biology, physics.

[22]  M. Kris,et al.  Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  C. Burman,et al.  Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. , 1993, International journal of radiation oncology, biology, physics.

[24]  D M Shepard,et al.  Application of constrained optimization to radiotherapy planning. , 1999, Medical physics.

[25]  L. Boersma,et al.  Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  D. González González,et al.  Prognostic factors of inoperable localized lung cancer treated by high dose radiotherapy. , 1983, International journal of radiation oncology, biology, physics.

[27]  M. Saunders,et al.  The long-term outcome after radical radiotherapy for advanced localized non-small cell carcinoma of the lung. , 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).

[28]  P Baas,et al.  Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer. , 2000, International journal of radiation oncology, biology, physics.

[29]  C. Perez,et al.  Impact of tumor control on survival in carcinoma of the lung treated with irradiation. , 1986, International journal of radiation oncology, biology, physics.

[30]  M T Munley,et al.  Incorporation of functional status into dose-volume analysis. , 1999, Medical physics.

[31]  R. Jaszczak,et al.  Relating radiation-induced regional lung injury to changes in pulmonary function tests. , 2001, International journal of radiation oncology, biology, physics.

[32]  J A Purdy,et al.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.

[33]  R Mohan,et al.  Application of fast simulated annealing to optimization of conformal radiation treatments. , 1993, Medical physics.